Google
Trusted Resources: News & Events
Latest announcements and gatherings
GBT launches ACCEL grants program to improve access to care for people with Sickle cell disease
Global Blood Therapeutics, Inc. (GBT) today announced the launch of the Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) to provide grant funding to support novel projects aimed at improving access to high-quality healthcare for sickle cell patients in the United States.
GBT will fund as many as three proposals up to $50,000 each to accelerate the development of promising programs with the potential over time to deliver high-quality healthcare to people living with sickle cell disease (SCD).
“Studies show that healthcare delivery to people living with SCD is typically suboptimal. For example, in the United States, fewer than 10 percent of Medicaid and Medicare patients living with SCD see a hematologist at least once per year and approximately 20 percent of SCD patients receive most of their care in the emergency room,” said Jung Choi, who oversees patient advocacy and government affairs at GBT.
+myBinderRelated Content
-
Antigua and Barbuda Sickle Cell AssociationThe Antigua and Barbuda Sickle Cell Asso...
-
Patriots’ Devin McCourty raises awareness about sickle cell diseaseTwo-time Super Bowl champion, pro-bowler...
-
Piedmont Health Services and Sickle Cell Agency 11th Annual Sickle Cell Charity RideJoin us for a fun and exciting motorcycl...
-
Ask Me Anything Blood Donor Educational WebinarJoin us for our next 1-hour virtual educ...
-
Under The Radar: Sickle Cell DiseaseIn the U.S., an estimated 100,000 Americ...
-
Thalassaemia & Sickle Cell Society of AustraliaThe Thalassaemia and Sickle Cell Society...
-
Uganda Sickle Cell Rescue FoundationIn July 2013, Uganda Sickle Cell Rescue ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.